Service Platform for ADC Discovery and Development
Capabilities
Pharmaron supports ADC discovery and development with its fully integrated ADC platform. Through innovative design, we combine advanced antibody discovery, payload screening, and expert bioconjugation to address critical challenges such as solubility and Drug-Antibody Ratio (DAR). We specialize in delivering customized ADC solutions designed to meet the unique needs of our clients. Whether it’s standalone projects involving one or multiple services or comprehensive end-to-end programs, we ensure tailored support every step of the way.
Key Features of Pharmaron’s ADC Discovery Services:
- Expertise in antibody discovery, payload and linker design, and bioconjugation.
- Advanced efficacy testing with robust in vitro and animal models.
- Complete in vitro and in vivo DMPK assessments.
- Successfully delivered 340 ADCs in 2024.
Key Features of Pharmaron’s Preclinical ADC Development Services:
- Bioanalysis and PK/PD characterization across all ADC components
- Full-service safety assessment including rodent and non-rodent animal testing
- Seamless manufacturing from pilot batches to tox batches and GMP batches supporting clinical trials
- Regulatory-compliant IND-enabling studies and submission support
Download our brochure to explore example studies and results.